ReviewAntibiotics (Basel, Switzerland)2023

Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens.

Michaël Thy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.